In this study, we demonstrate that graphene oxide (GO) can be used for the delivery of bone
morphogenetic protein-2 (BMP-2) and substance P (SP), and that this delivery promotes …

Lack of bioactivity has seriously restricted the development of biodegradable implants for
bone tissue engineering. Therefore, surface modification of the composite is crucial to …

High doses of bone morphogenetic protein-2 (BMP-2) are required for effective bone
regeneration. However, these high doses often cause undesirable adverse effects, including …

The therapeutic efficacy of drugs often depends on the drug delivery carrier. For efficient
delivery of therapeutic proteins, delivery carriers should enable the loading of large doses …

Graphene oxide (GO) consisting of a carbon monolayer has been widely investigated for
tissue engineering platforms because of its unique properties. For this study, we fabricated a …

The potential of graphene-based nanoparticles (GNPs) has recently gained significant
attention in biomedicine, especially in tissue engineering. In this study, we investigated the …

We has synthesized the biocompatible gelatin reduced graphene oxide (GOG) in previous
research, and in this study we would further evaluate its effects on bone remodeling in the …

Recently, graphene-based nanomaterials, in the form of two dimensional substrates or three
dimensional foams, have attracted considerable attention as bioactive scaffolds to promote …

Graphene has been studied for its in vitro osteoinductive capacity. However, the in vivo bone
repair effects of graphene‐based scaffolds remain unknown. The aqueous soluble …

Osteoprogenitor cells play a significant role in the growth or repair of bones, and have great
potential as cell sources for regenerative medicine and bone tissue engineering, but control …